Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): Its impact on drug disposition

Advanced Drug Delivery Reviews

Volumn 54, Issue 10, 2002, Pages 1311-1331

  Suzuki, Hiroshi ^a   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; PATIENT MONITORING; PROTEINS; SUBSTRATES;

MUTATIONS;

DRUG PRODUCTS;

4 AMINOHIPPURIC ACID; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; AMPICILLIN; BROMSULFOPHTHALEIN; CARBOXYFLUORESCEIN; CEFODIZIME; CEFTRIAXONE; CISPLATIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIBROMOSULFOPHTHALEIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GREPAFLOXACIN; IRINOTECAN; MULTIDRUG RESISTANCE PROTEIN 2; PRAVASTATIN; SULFINPYRAZONE; TEMOCAPRILAT; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; CARRIER PROTEIN; DRUG; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2;

BILIARY EXCRETION; DOWN REGULATION; DRUG DISPOSITION; DRUG TRANSPORT; DUBIN JOHNSON SYNDROME; EPITHELIUM CELL; INTRAHEPATIC BILE DUCT; MULTIDRUG RESISTANCE; MUTATION; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; BILE; BIOSYNTHESIS; ENZYME SPECIFICITY; GENETICS; HUMAN; LIVER; METABOLISM; RAT; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BILE; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, MULTIPLE; HUMANS; LIVER; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHARMACEUTICAL PREPARATIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION;

EID: 0037131880     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00075-3     Document Type: Article

References (185)

1. Wedlund P.J. The CYP2C19 enzyme polymorphism. Pharmacology. 61:2000;174-183.
2. Goldstein J.A. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br. J. Clin. Pharmacol. 52:2001;349-355.
3. Anzenbacher P., Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 58:2001;737-747.
4. Lin J.H., Lu A.Y. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Ann. Rev. Pharmacol. Toxicol. 41:2001;535-567.
5. Whitlock J.P. Induction of cytochrome P4501A1. Ann. Rev. Pharmacol. Toxicol. 39:1999;103-125.
6. Sueyoshi T., Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Ann. Rev. Pharmacol. Toxicol. 41:2001;123-143.
7. Suzuki H., Sugiyama Y. Transporters for bile acids and organic anions. Amidon G.L., Sadee W., Membrane Transporters as Drug Targets. 1999;387-439 Kluwer Academic/Plenum Publishers, New York.
8. Kusuhara H., Sugiyama Y. Drug-drug interactions involving the membrane transport. Rodrigues A.D., Drug-Drug Interactions. 2001;123-188 Marcel Dekker, New York.
9. Kusuhara H., Sugiyama Y. Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J. Control. Rel. 78:2002;43-54.
10. Mizuno N., Sugiyama Y. Drug transporters: their role and importance in new drug selection and development. Drug Metab Pharmacokin. 17:2002;93-108.
11. Russel F.G., Masereeuw R., van Aubel R.A. Molecular aspects of renal anionic drug transport. Ann. Rev. Physiol. 64:2002;563-594.
12. Schellens J.H., Malingre M.M., Kruijtzer C.M., Bardelmeijer H.A., van Tellingen O., Schinkel A.H., Beijnen J.H. Modulation of oral bioavailability of anticancer drugs: from mouse to man. Eur. J. Pharm. Sci. 12:2000;103-110.
13. Koepsell H., Gorboulev V., Arndt P. Molecular pharmacology of organic cation transporters in kidney. J. Membr. Biol. 167:1999;103-117.
14. Sekine T., Cha S.H., Endou H. The multispecific organic anion transporter (OAT) family. Pflugers Arch. 440:2000;337-350.
15. Ayrton A., Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica. 31:2001;469-497.
16. Hoffmeyer S., Burk O., von Richter O., Arnold H.P., Brockmoller J., Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M., Brinkmann U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA. 97:2000;3473-3478.
17. Kim R.B., Leake B.F., Choo E.F., Dresser G.K., Kubba S.V., Schwarz U.I., Taylor A., Xie H.G., McKinsey J., Zhou S., Lan L.B., Schuetz J.D., Schuetz E.G., Wilkinson G.R. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther. 70:2001;189-199.
18. Hsiang B., Zhu Y., Wang Z., Wu Y., Sasseville V., Yang W.P., Kirchgessner T.G. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J. Biol. Chem. 274:1999;37161-37168.
19. Nakai D., Nakagomi R., Furuta Y., Tokui T., Abe T., Ikeda T., Nishimura K. Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes. J. Pharmacol. Exp. Ther. 287:2001;861-867.
20. Suzuki H., Sugiyama Y. Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liver. Semin. Liver Dis. 20:2000;251-263.
21. Sasaki M., Suzuki H., Ito K., Abe T., Sugiyama Y. Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and multidrug resistance-associated protein 2 (MRP2/ABCC2). J. Biol. Chem. 277:2002;6497-6503.
22. Tirona R.G., Leake B.F., Merino G., Kim R.B. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J. Biol. Chem. 276:2001;35669-35675.
23. Suzuki H., Sugiyama Y. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2. Semin. Liver Dis. 18:1998;359-376.
24. Suzuki H., Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 12:2000;3-12.
25. König J., Nies A.T., Cui Y., Leier I., Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta. 1461:1999;377-394.
26. Keppler D., König H. Hepatic secretion of conjugated drugs and endogenous substances. Semin. Liver Dis. 20:2000;265-272.
27. Paulusma C.C., Oude Elferink R.P. The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man. J. Mol. Med. 75:1997;420-428.
28. Leier I., Jedlitschky G., Buchholz U., Cole S.P., Deeley R.G., Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269:1994;27807-27810.
29. Jedlitschky G., Leier I., Buchholz U., Center M., Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res. 54:1994;4833-4836.
30. Müller M., Meijer C., Zaman G.J., Borst P., Scheper R.J., Mulder N.H., de Vries E.G., Jansen P.L. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA. 91:1994;13033-13037.
31. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
32. Hipfner D.R., Deeley R.G., Cole S.P. Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta. 1461:1999;359-376.
33. Leslie E.M., Deeley R.G., Cole S.P. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology. 167:2001;3-23.
34. Paulusma C.C., Bosma P.J., Zaman G.J., Bakker C.T., Otter M., Scheffer G.L., Scheper R.J., Borst P., Oude Elferink R.P. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science. 271:1996;1126-1128.
35. Büchler M., König J., Brom M., Kartenbeck J., Spring H., Horie T., Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J. Biol. Chem. 271:1996;15091-15098.
36. Taniguchi K., Wada M., Kohno K., Nakamura T., Kawabe T., Kawakami M., Kagotani K., Okumura K., Akiyama S., Kuwano M. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 56:1996;4124-4129.
37. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am. J. Physiol. 272:1997;G16-G22.
38. Madon J., Eckhardt U., Gerloff T., Stieger B., Meier P.J. Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein. FEBS Lett. 406:1997;75-78.
39. Fritz F., Chen J., Hayes P., Sirotnak F.M. Molecular cloning of the murine cMOAT ATPase. Biochim. Biophys. Acta. 1492:2000;531-536.
40. van Aubel R.A., van Kuijck M.A., Koenderink J.B., Deen P.M., van Os C.H., Russel F.G. Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells. Mol. Pharmacol. 53:1998;1062-1067.
41. Conrad S., Viertelhaus A., Orzechowski A., Hoogstraate J., Gjellan K., Schrenk D., Kauffmann H.M. Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1. Toxicology. 156:2001;81-91.
42. Koike K., Kawabe T., Tanaka T., Toh S., Uchiumi T., Wada M., Akiyama S., Ono M., Kuwano M. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res. 57:1997;5475-5479.
43. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y. Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver. J. Biol. Chem. 273:1998;1684-1688.
44. Evers R., Kool M., van Deemter L., Janssen H., Calafat J., Oomen L.C., Paulusma C.C., Oude Elferink R.P., Baas F., Schinkel A.H., Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101:1998;1310-1319.
45. van Aubel R.A., van Kuijck M.A., Koenderink J.B., Deen P.M., van Os C.H., Russel F.G. Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells. Mol. Pharmacol. 53:1998;1062-1067.
46. Kinoshita S., Suzuki H., Ito K., Kume K., Shimizu T., Sugiyama Y. Transfected rat cMOAT is functionally expressed on the apical membrane in Madin-Darby canine kidney (MDCK) cells. Pharm. Res. 15:1998;1851-1856.
47. Cui Y., König J., Buchholz J.K., Spring H., Leier I., Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol. 55:1999;929-937.
48. Kamisako T., Leier I., Cui Y., Konig J., Buchholz U., Hummel-Eisenbeiss J., Keppler D. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology. 30:1999;485-490.
49. Kawabe T., Chen Z.S., Wada M., Uchiumi T., Ono M., Akiyama S., Kuwano M. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2). FEBS Lett. 456:1999;327-331.
50. Paulusma C.C., van Geer M.A., Evers R., Heijn M., Ottenhoff R., Borst P., Oude Elferink R.P. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem. J. 338:1999;393-401.
51. van Aubel R.A., Koenderink J.B., Peters J.G., van Os C.H., Russel F.G. Mechanisms and interaction of vinblastine and reduced glutathione transport in membrane vesicles by the rabbit multidrug resistance protein Mrp2 expressed in insect cells. Mol. Pharmacol. 56:1999;714-719.
52. Bakos E., Evers R., Sinko E., Varadi A., Borst P., Sarkadi B. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol. 57:2000;760-768.
53. Evers R., de Haas M., Sparidans R., Beijnen J., Wielinga P.R., Lankelma J., Borst P. Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br. J. Cancer. 83:(3):2000;375-383.
54. Leier I., Hummel-Eisenbeiss J., Cui Y., Keppler D. ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int. 57:2000;1636-1642.
55. van Aubel R.A., Peters J.G., Masereeuw R., van Os C.H., Russel F.G. Multidrug resistance protein mrp2 mediates ATP-dependent transport of classic renal organic anion p-aminohippurate. Am. J. Physiol. 279:2000;F713-F717.
56. Cui Y., Konig J., Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol. Pharmacol. 60:2001;934-943.
57. Dietrich C.G., de Waart D.R., Ottenhoff R., Bootsma A.H., van Gennip A.H., Elferink R.P. Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis. 22:2001;805-811.
58. Dietrich C.G., de Waart D.R., Ottenhoff R., Schoots I.G., Elferink R.P. Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. Mol. Pharmacol. 59:2001;974-980.
59. K. Ito, H. Suzuki, T. Horie, Y. Sugiyama, Mechanism for the ATP-dependent transport of reduced glutathione and glutathione-conjugates by rat Mrp2, Abstract for the 3rd FEBS Advanced Lecture Course ATP-Binding Cassette Proteins: From Genetic Disease to Multidrug Resistance, March 3rd-10th, 2001, Gosau, Austria, p. 152.
60. Leslie E.M., Ito K., Upadhyaya P., Hecht S.S., Deeley R.G., Cole S.P. Transport of the beta-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J. Biol. Chem. 276:2001;27846-27854.
61. Srivastava S.K., Watkins S.C., Schuetz E., Singh S.V. Role of glutathione conjugate efflux in cellular protection against benzo[a]pyrene-7,8-diol-9,10-epoxide -induced DNA damage. Mol. Carcinog. 33:2002;156-162.
62. Jedlitschky G., Leier I., Buchholz U., Hummel-Eisenbeiss J., Burchell B., Keppler D. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem. J. 327:1997;305-310.
63. Koopen N.R., Wolters H., Havinga R., Vonk R.J., Jansen P.L., Muller M., Kuipers F. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat. Hepatology. 27:1998;537-545.
64. Rebbeor J.F., Connolly G.C., Ballatori N. Inhibition of Mrp2- and Ycf1p-mediated transport by reducing agents: evidence for GSH transport on rat Mrp2. Biochim. Biophys. Acta. 1559:2002;171-178.
65. Bohme M., Jedlitschky G., Leier I., Buchler M., Keppler D. ATP-dependent export pumps and their inhibition by cyclosporins. Adv. Enzyme Regul. 34:1994;371-380.
66. Stieger B., Fattinger K., Madon J., Kullak-Ublick G.A., Meier P.J. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology. 118:2000;422-430.
67. Huang L., Smit J.W., Meijer D.K., Vore M. Mrp2 is essential for estradiol-17β (β-D-glucuronide)-induced cholestasis in rats. Hepatology. 32:2000;66-72.
68. Akita H., Suzuki H., Ito K., Kinoshita S., Sato N., Takikawa H., Sugiyama Y. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump. Biochim. Biophys. Acta. 1511:2001;7-16.
69. Han Y.H., Kato Y., Haramura M., Ohta M., Matsuoka H., Sugiyama Y. Physicochemical parameters responsible for the affinity of methotrexate analogs for rat canalicular multispecific organic anion transporter (cMOAT/MRP2). Pharm. Res. 18:2001;579-586.
70. Niinuma K., Kato Y., Suzuki H., Tyson C.A., Weizer V., Dabbs J.E., Froehlich R., Green C.E., Sugiyama Y. Primary active transport of organic anions on bile canalicular membrane in humans. Am. J. Physiol. 276:1999;G1153-G1164.
71. Ishizuka H., Konno K., Shiina T., Naganuma H., Nishimura K., Ito K., Suzuki H., Sugiyama Y. Species differences in the transport activity for organic anions across the bile canalicular membrane. J. Pharmacol. Exp. Ther. 290:1999;1324-1330.
72. van Aubel R.A., Hartog A., Bindels R.J., van Os C.H., Russel F.G. Expression and immunolocalization of multidrug resistance protein 2 in rabbit small intestine. Eur. J. Pharmacol. 400:2000;195-198.
73. Mottino A.D., Hoffman T., Jennes L., Vore M. Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J. Pharmacol. Exp. Ther. 293:2000;717-723.
74. Rost D., Mahner S., Sugiyama Y., Stremmel W. Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. Am. J. Physiol. 282:2002;G720-G726.
75. Mottino A.D., Hoffman T., Jennes L., Cao J., Vore M. Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats. Am. J. Physiol. 280:2001;G1261-G1273.
76. Gotoh Y., Suzuki H., Kinoshita S., Hirohashi T., Kato Y., Sugiyama Y. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. J. Pharmacol. Exp. Ther. 292:2000;433-439.
77. Naruhashi K., Tamai I., Inoue N., Muraoka H., Sai Y., Suzuki N., Tsuji A. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats. Antimicrob. Agents Chemother. 46:2002;344-349.
78. de Vries M.H., Redegeld F.A., Koster A.S., Noordhoek J., de Haan J.G., Oude Elferink R.P., Jansen P.L. Hepatic, intestinal and renal transport of 1-naphthol-beta-D-glucuronide in mutant rats with hereditary-conjugated hyperbilirubinemia. Naunyn Schmiedebergs Arch. Pharmacol. 340:1989;588-592.
79. Okudaira N., Komiya I., Sugiyama Y. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine. J. Pharmacol. Exp. Ther. 295:2000;717-723.
80. Okudaira N., Tatebayashi T., Speirs G.C., Komiya I., Sugiyama Y. A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug. J. Pharmacol. Exp. Ther. 294:2000;580-587.
81. Schaub T.P., Kartenbeck J., Konig J., Vogel O., Witzgall R., Kriz W., Keppler D. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J. Am. Soc. Nephrol. 8:1997;1213-1221.
82. Schaub T.P., Kartenbeck J., Konig J., Spring H., Dorsam J., Staehler G., Storkel S., Thon W.F., Keppler D. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J. Am. Soc. Nephrol. 10:1999;1159-1169.
83. Lee J., Azzaroli F., Wang L., Soroka C.J., Gigliozzi A., Setchell K.D., Kramer W., Boyer J.L. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology. 121:2001;1473-1484.
84. Tanaka Y., Kobayashi Y., Gabazza E.C., Higuchi K., Kamisako T., Kuroda M., Takeuchi K., Iwasa M., Kaito M., Adachi Y. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am. J. Physiol. 282:2002;G656-G662.
85. Demeule M., Brossard M., Beliveau R. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am. J. Physiol. 277:1999;F832-F840.
86. St-Pierre M.V., Serrano M.A., Macias R.I., Dubs U., Hoechli M., Lauper U., Meier P.J., Marin J.J. Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. 279:2000;R1495-R1503.
87. Rost D., Konig J., Weiss G., Klar E., Stremmel W., Keppler D. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology. 121:2001;1203-1208.
88. Miller D.S., Nobmann S.N., Gutmann H., Toeroek M., Drewe J., Fricker G. Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol. Pharmacol. 58:2000;1357-1367.
89. Miller D.S., Graeff C., Droulle L., Fricker S., Fricker G. Xenobiotic efflux pumps in isolated fish brain capillaries. Am. J. Physiol. 282:2002;R191-R198.
90. Zhang Y., Han H., Elmquist W.F., Miller D.W. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res. 876:2000;148-153.
91. Arts H.J., Katsaros D., de Vries E.G., Massobrio M., Genta F., Danese S., Arisio R., Scheper R.J., Kool M., Scheffer G.L., Willemse P.H., van der Zee A.G., Suurmeijer A.J. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. Clin. Cancer Res. 5:1999;2798-2805.
92. Hinoshita E., Uchiumi T., Taguchi K., Kinukawa N., Tsuneyoshi M., Maehara Y., Sugimachi K., Kuwano M. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin. Cancer Res. 6:2000;2401-2407.
93. van Der Kolk D.M., Vellenga E., van Der Veen A.Y., Noordhoek L., Timmer-Bosscha H., Ossenkoppele G.J., Raymakers R.A., Muller M., van Den Berg E., de Vries E.G. Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity. Blood. 95:2000;3514-3519.
94. van der Kolk D.M., de Vries E.G., Noordhoek L., van den Berg E., van der Pol M.A., Muller M., Vellenga E. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia. Leukemia. 15:2001;1544-1553.
95. Soini Y., Jarvinen K., Kaarteenaho-Wiik R., Kinnula V. The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma. Ann. Oncol. 12:2001;1239-1245.
96. Nies A.T., Konig J., Pfannschmidt M., Klar E., Hofmann W.J., Keppler D. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int. J. Cancer. 94:2001;492-499.
97. Guo A., Marinaro W., Hu P., Sinko P.J. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). Drug Metab. Dispos. 30:2002;457-463.
98. Borst P., Evers R., Kool M., Wijnholds J. The multidrug resistance protein family. Biochim. Biophys. Acta. 1461:1999;347-357.
99. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:2000;1295-1302.
100. Tsujii H., Konig J., Rost D., Stockel B., Leuschner U., Keppler D. Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. Gastroenterology. 117:1999;653-660.
101. Toh S., Wada M., Uchiumi T., Inokuchi A., Makino Y., Horie Y., Adachi Y., Sakisaka S., Kuwano M. Genomic structure of the canalicular multispecific organic anion transporter gene (MRP2/cMOAT) and mutations in the ATP-binding cassette region in Dubin-Johnson syndrome. Am. J. Hum. Genet. 64:1999;739-746.
102. Paulusma C.C., Kool M., Bosma P.J., Scheffer G.L., ter Borg F., Scheper R.J., Tytgat G.N., Borst P., Baas F., Oude Elferink R.P. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology. 25:1997;1539-1542.
103. Wada M., Toh S., Taniguchi K., Nakamura T., Uchiumi T., Kohno K., Yoshida I., Kimura A., Sakisaka S., Adachi Y., Kuwano M. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum. Mol. Genet. 7:1998;203-207.
104. Kajihara S., Hisatomi A., Mizuta T., Hara T., Ozaki I., Wada I., Yamamoto K. A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome. Biochem. Biophys. Res. Commun. 253:1998;454-457.
105. Kagawa T., Sato M., Hosoi K., Uchiyama J., Nishizaki Y., Watanabe N., Inagaki Y., Kimura M., Matsuzaki S. Absence of R1066X mutation in six Japanese patients with Dubin-Johnson syndrome. Biochem. Mol. Biol. Int. 47:1999;639-644.
106. Keitel V., Kartenbeck J., Nies A.T., Spring H., Brom M., Keppler D. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology. 32:2000;1317-1328.
107. Mor-Cohen R., Zivelin A., Rosenberg N., Shani M., Muallem S., Seligsohn U. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J. Biol. Chem. 276:2001;36923-36930.
108. H. Suzuki, J. Shoda, M. Kano, Y. Matsuzaki, N. Tanaka, T. Hirouchi, H. Suzuki, Y. Sugiyama, H. Utsunomiya, K. Oda, Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2) gene in a Japanese patient with Dubin-Johnson syndrome (DJS), Gastroenterol (2002) in press.
109. Ito K., Suzuki H., Sugiyama Y. Charged amino acids in the transmembrane domains are involved in the determination of the substrate specificity of rat Mrp2. Mol. Pharmacol. 59:2001;1077-1085.
110. Ito K., Suzuki H., Sugiyama Y. Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate. Am. J. Physiol. 281:2001;G1034-G1043.
111. Ryu S., Kawabe T., Nada S., Yamaguchi A. Identification of basic residues involved in drug export function of human multidrug resistance-associated protein 2. J. Biol. Chem. 275N:2000;39617-39624.
112. 1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J. Biol. Chem. 276:2001;38108-38114.
113. Bezprozvanny I., Maximov A. PDZ domains: More than just a glue. Proc. Natl. Acad. Sci. USA. 98:2001;787-789.
114. Sheng M., Sala C. PDZ domains and the organization of supramolecular complexes. Ann. Rev. Neurosci. 24:2001;1-29.
115. Kocher O., Comella N., Gilchrist A., Pal R., Tognazzi K., Brown L.F., Knoll J.H. PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. Lab. Invest. 79:(9):1999;1161-1170.
116. Harris M.J., Kuwano M., Webb M., Board P.G. Identification of the apical membrane-targeting signal of the multidrug resistance-associated protein 2 (MRP2/MOAT). J. Biol. Chem. 276:2001;20876-20881.
117. A.T. Nies, J. Konig, Y. Cui, M. Brom, H. Spring, D. Keppler, Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2), Eur J Biol Chem 269 (2002) in press.
118. Ito S., Ieiri I., Tanabe M., Suzuki A., Higuchi S., Otubo K. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics. 11:2001;175-184.
119. Itoda M., Saito Y., Soyama A., Saeki M., Murayama N., Ishida S., Sai K., Nagano M., Suzuki H., Sugiyama Y., Ozawa S., Sawada J. Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5′-untranslated region and exon 28. Drug Metab. Dispos. 30:2002;363-364.
120. Hooiveld G.J., van Montfoort J.E., Meijer D.K., Muller M. Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport. Eur. J. Pharm. Sci. 12:2001;525-543.
121. Vos T.A., Hooiveld G.J., Koning H., Childs S., Meijer D.K., Moshage H., Jansen P.L., Muller M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter. Spgp, in endotoxemic rat liver. Hepatology. 28:1998;1637-1644.
122. Rost D., Kartenbeck J., Keppler D. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology. 29:1999;814-821.
123. Paulusma C.C., Kothe M.J., Bakker C.T., Bosma P.J., van Bokhoven I., van Marle J., Bolder U., Tytgat G.N., Oude Elferink R.P. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology. 31:2000;684-693.
124. Dombrowski F., Kubitz R., Chittattu A., Wettstein M., Saha N., Haussinger D. Electron-microscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide. Biochem. J. 348:2000;183-188.
125. Shoda J., Kano M., Oda K., Kamiya J., Nimura Y., Suzuki H., Sugiyama Y., Miyazaki H., Todoroki T., Stengelin S., Kramer W., Matsuzaki Y., Tanaka N. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am. J. Gastroenterol. 96:2001;3368-3378.
126. Zollner G., Fickert P., Zenz R., Fuchsbichler A., Stumptner C., Kenner L., Ferenci P., Stauber R.E., Krejs G.J., Denk H., Zatloukal K., Trauner M. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology. 33:2001;633-646.
127. Schmitt M., Kubitz R., Wettstein M., vom Dahl S., Haussinger D. Retrieval of the mrp2 gene encoded conjugate export pump from the canalicular membrane contributes to cholestasis induced by tert-butyl hydroperoxide and chloro-dinitrobenzene. Biol. Chem. 381:2000;487-495.
128. Kubitz R., Huth C., Schmitt M., Horbach A., Kullak-Ublick G., Haussinger D. Protein kinase C-dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells. Hepatology. 34:2001;340-350.
129. Roelofsen H., Soroka C.J., Keppler D., Boyer J.L. Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets. J Cell Sci. 111:1998;1137-1145.
130. Fickert P., Zollner G., Fuchsbichler A., Stumptner C., Pojer C., Zenz R., Lammert F., Stieger B., Meier P.J., Zatloukal K., Denk H., Trauner M. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology. 121:2001;170-183.
131. Beuers U., Bilzer M., Chittattu A., Kullak-Ublick G.A., Keppler D., Paumgartner G., Dombrowski F. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology. 35:2001;1206-1216.
132. Nakamura J., Nishida T., Hayashi K., Kawada N., Ueshima S., Sugiyama Y., Ito T., Sobue K., Matsuda H. Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression. Biochem. Biophys. Res. Commun. 255:1999;143-149.
133. Hinoshita E., Taguchi K., Inokuchi A., Uchiumi T., Kinukawa N., Shimada M., Tsuneyoshi M., Sugimachi K., Kuwano M. Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J. Hepatol. 35:2001;765-773.
134. Kauffmann H.M., Schrenk D. Sequence analysis and functional characterization of the 5′-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. Biochem. Biophys. Res. Commun. 245:1998;325-331.
135. Tanaka T., Uchiumi T., Hinoshita E., Inokuchi A., Toh S., Wada M., Takano H., Kohno K., Kuwano M. The human multidrug resistance protein 2 gene: Functional characterization of the 5′-flanking region and expression in hepatic cells. Hepatology. 30:1999;1507-1712.
136. Stockel B., Konig J., Nies A.T., Cui Y., Brom M., Keppler D. Characterization of the 5′-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison with the multidrug resistance protein 3 (MRP3) gene. Eur. J. Biochem. 267:2000;1347-1358.
137. Kast H.R., Goodwin B., Tarr P.T., Jones S.A., Anisfeld A.M., Stoltz C.M., Tontonoz P., Kliewer S., Willson T.M., Edwards P.A. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277:2002;2908-2915.
138. Courtois A., Payen L., Le Ferrec E., Scheffer G.L., Trinquart Y., Guillouzo A., Fardel O. Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. Biochem. Pharmacol. 63:2002;333-341.
139. Zhang J., Kuehl P., Green E.D., Touchman J.W., Watkins P.B., Daly A., Hall S.D., Maurel P., Relling M., Brimer C., Yasuda K., Wrighton S.A., Hancock M., Kim R.B., Strom S., Thummel K., Russell C.G., Hudson Jr J.R., Schuetz E.G., Boguski M.S. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics. 11:2001;555-572.
140. Forman B.M. Polymorphisms in promiscuous PXR: an explanation for interindividual differences in drug clearance? Pharmacogenetics. 11:2001;551-552.
141. Hustert E., Zibat A., Presecan-Siedel E., Eiselt R., Mueller R., Fuss C., Brehm I., Brinkmann U., Eichelbaum M., Wojnowski L., Burk O. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metab. Dispos. 29:2001;1454-1459.
142. Fromm M.F., Kauffmann H.M., Fritz P., Burk O., Kroemer H.K., Warzok R.W., Eichelbaum M., Siegmund W., Schrenk D. The effect of rifampin treatment on intestinal expression of human MRP transporters. Am. J. Pathol. 157:2000;1575-1680.
143. Gibaldi M., Perrier D., Pharmacokinetics. 2nd Edition:1982;319-353 Marcel Dekker, New York.
144. Miyauchi S., Sugiyama Y., Iga T., Hanano M. Membrane limited hepatic transport of conjugative metabolites of 4-methylumbelliferone in rats. J. Pharm. Sci. 77:1988;688.
145. Liu X., LeCluyse E.L., Brouwer K.R., Gan L.S., Lemasters J.J., Stieger B., Meier P.J., Brouwer K.L. Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am. J. Physiol. 277:1999;G12-G21.
146. Guhlmann A., Krauss K., Oberdorfer F., Siegel T., Scheuber P.H., Muller J., Csuk-Glanzer B., Ziegler S., Ostertag H., Keppler D. Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomography. Hepatology. 21:1995;1568-1575.
147. B. Ji, K. Ito, H. Suzuki, Y. Sugiyama, T. Horie, Multidrug resistance-associated Protein2 (MRP2) plays an important role in the biliary excretion of glutathione conjugates of 4-hydroxynonenal in vitro and in vivo, Hepatology (ABSTRACT).
148. Dietrich C.G., Ottenhoff R., de Waart D.R., Oude Elferink R.P. Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology. 167:2001;73-81.
149. Kala S.V., Neely M.W., Kala G., Prater C.I., Atwood D.W., Rice J.S., Lieberman M.W. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275:2000;33404-33408.
150. Nishino A., Kato Y., Igarashi T., Sugiyama Y. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan. Drug Metab. Dispos. 28:2000;1146-1148.
151. Xiong H., Turner K.C., Ward E.S., Jansen P.L., Brouwer K.L. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats. J. Pharmacol. Exp. Ther. 295:2000;512-518.
152. Seitz S., Kretz-Rommel A., Oude Elferink R.P., Boelsterli U.A. Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2). Chem. Res. Toxicol. 11:1998;513-519.
153. Kouzuki H., Suzuki H., Sugiyama Y. Pharmacokinetic study of the hepatobiliary transport of indomethacin. Pharm. Res. 17:2000;432-438.
154. Nies A.T., Cantz T., Brom M., Leier I., Keppler D. Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line. WIF-B. Hepatology. 28:1998;332-340.
155. Kim P.K., Chen J., Andrejko K.M., Deutschman C.S. Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats. Shock. 14:2000;176-181.
156. Oswald M., Kullak-Ublick G.A., Paumgartner G., Beuers U. Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. Liver. 21:2001;247-253.
157. Donner M.G., Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology. 34:2001;351-359.
158. Trauner M., Arrese M., Soroka C.J., Ananthanarayanan M., Koeppel T.A., Schlosser S.F., Suchy F.J., Keppler D., Boyer J.L. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology. 113:1997;255-264.
159. Ogawa K., Suzuki H., Hirohashi T., Ishikawa T., Meier P.J., Hirose K., Akizawa T., Yoshioka M., Sugiyama Y. Characterization of inducible nature of MRP3 in rat liver. Am. J. Physiol. 278:2000;G438-G446.
160. Tang W., Yi C., Kalitsky J., Piquette-Miller M. Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. Mol. Cell. Biol. Res. Commun. 4:2000;90-97.
161. Kubitz R., Wettstein M., Warskulat U., Haussinger D. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology. 116:1999;401-410.
162. Vos T.A., Ros J.E., Havinga R., Moshage H., Kuipers F., Jansen P.L., Muller M. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology. 29:1999;1833-1839.
163. Gerloff T., Geier A., Stieger B., Hagenbuch B., Meier P.J., Matern S., Gartung C. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterology. 117:1999;1408-1415.
164. Habib G.M., Shi Z.Z., Ou C.N., Kala G., Kala S.V., Lieberman M.W. Altered gene expression in the liver of gamma-glutamyl transpeptidase-deficient mice. Hepatology. 32:2000;556-562.
165. Cao J., Huang L., Liu Y., Hoffman T., Stieger B., Meier P.J., Vore M. Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin. Hepatology. 33:2001;140-147.
166. Laouari D., Yang R., Veau C., Blanke I., Friedlander G. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. Am. J. Physiol. Renal. Physiol. 280:2001;F636-F645.
167. Denson L.A., Auld K.L., Schiek D.S., McClure M.H., Mangelsdorf D.J., Karpen S.J. Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J. Biol. Chem. 275:2000;8835-8843.
168. Kauffmann H.M., Pfannschmidt S., Zoller H., Benz A., Vorderstemann B., Webster J.I., Schrenk D. Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression. Toxicology. 171:2002;137-146.
169. Bock K.W., Eckle T., Ouzzine M., Fournel-Gigleux S. Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells. Biochem. Pharmacol. 59:2000;467-470.
170. Payen L., Courtois A., Loewert M., Guillouzo A., Fardel O. Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane. Biochem. Biophys. Res. Commun. 282:2001;257-263.
171. Lin-Lee Y.C., Tatebe S., Savaraj N., Ishikawa T., Tien Kuo M. Differential sensitivities of the MRP gene family and gamma-glutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status. Biochem. Pharmacol. 61:2001;555-563.
172. Johnson D.R., Habeebu S.S., Klaassen C.D. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2. Toxicol. Sci. 66:2002;16-26.
173. Hagenbuch N., Reichel C., Stieger B., Cattori V., Fattinger K.E., Landmann L., Meier P.J., Kullak-Ublick G.A. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. J. Hepatol. 34:2001;881-887.
174. Cherrington N.J., Hartley D.P., Li N., Johnson D.R., Klaassen C.D. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J. Pharmacol. Exp. Ther. 300:2002;97-104.
175. Schrenk D., Baus P.R., Ermel N., Klein C., Vorderstemann B., Kauffmann H.M. Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol. Lett. 120:2001;51-57.
176. Dussault I., Lin M., Hollister K., Wang E.H., Synold T.W., Forman B.M. Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR. J. Biol. Chem. 276:2001;33309-33312.
177. Kauffmann H.M., Keppler D., Gant T.W., Schrenk D. Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen. Arch. Toxicol. 72:1998;763-768.
178. Kubitz R., Warskulat U., Schmitt M., Haussinger D. Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes. Biochem. J. 340:1999;585-591.
179. Courtois A., Payen L., Guillouzo A., Fardel O. Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone. FEBS Lett. 459:1999;381-385.
180. Demeule M., Jodoin J., Beaulieu E., Brossard M., Beliveau R. Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett. 442:1999;208-214.
181. Vernhet L., Seite M.P., Allain N., Guillouzo A., Fardel O. Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes. J. Pharmacol. Exp. Ther. 298:2001;234-239.
182. Bramow S., Ott P., Thomsen Nielsen F., Bangert K., Tygstrup N., Dalhoff K. Cholestasis and regulation of genes related to drug metabolism and biliary transport in rat liver following treatment with cyclosporine A and sirolimus (Rapamycin). Pharmacol. Toxicol. 89:2001;133-139.
183. Kauffmann H.M., Keppler D., Kartenbeck J., Schrenk D. Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes. Hepatology. 26:1997;980-985.
184. Wielandt A.M., Vollrath V., Manzano M., Miranda S., Accatino L., Chianale J. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver. Biochem. J. 341:1999;105-111.
185. Courtois A., Payan L., Vernhet L., Morel F., Guillouzo A., Fardel O. Differential regulation of canalicular multispecific organic anion transporter (cMOAT) expression by the chemopreventive agent oltipraz in primary rat hepatocytes and in rat liver. Carcinogenesis. 20:1999;2327-2330.